Goodpasture syndrome is a rare autoimmune pathology characterized by periodically occurring pulmonary hemorrhages, the development of glomerulonephritis, and renal failure. Treatment of Goodpasture syndrome in Israel is carried out by specialists with a high level of qualification and extensive experience in autoimmune diseases. The effectiveness of therapy is also due to a multidisciplinary approach, involving pulmonologists, nephrologists, rheumatologists, and immunologists in the diagnosis, development, and implementation of the treatment program. The treatment regimen includes modern methods of conservative therapy, statistically improving prognosis and alleviating symptoms in approximately 83-85% of patients.
Goodpasture syndrome is a rare autoimmune pathology characterized by periodically occurring pulmonary hemorrhages, the development of glomerulonephritis, and renal failure. Treatment of Goodpasture syndrome in Israel is carried out by specialists with a high level of qualification and extensive experience in autoimmune diseases. The effectiveness of therapy is also due to a multidisciplinary approach, involving pulmonologists, nephrologists, rheumatologists, and immunologists in the diagnosis, development, and implementation of the treatment program. The treatment regimen includes modern methods of conservative therapy, statistically improving prognosis and alleviating symptoms in approximately 83-85% of patients.
Treatment Methods for the Disease
In Goodpasture syndrome, inflammation of the renal and pulmonary capillaries of immune origin develops, resulting in glomerulonephritis and hemorrhagic pneumonitis. The disease is named after the American pathophysiologist who first described it just over a hundred years ago. This syndrome is predominantly diagnosed in men, with a frequency of approximately 1:1,000,000. The absence of timely treatment is associated with a very negative prognosis and mortality in the majority of patients.
The exact causes of the disease are not fully understood; however, its association with viral pathologies, including influenza and hepatitis A, prolonged use of certain medications, inhalation of gasoline and varnish fumes, and smoking has been noted. There is also a hereditary predisposition. The influence of negative factors stimulates the production of autoantibodies to the membranes of the alveoli in the lungs and renal glomeruli. Studies have shown that the activation of T-lymphocytes, proteolytic enzymes, and free radicals, as well as the synthesis of cytokines such as interleukin-1 and platelet-derived growth factor, significantly influence the development of the autoimmune inflammatory process.
Malignant, moderate, and slow variants of the pathology are distinguished. Clinical signs of the malignant variant include pulmonary hemorrhages and acute renal failure. Moderate and slow variants manifest with characteristic symptoms of lung involvement (cough, shortness of breath, hemoptysis), subfebrile temperature, weakness, weight loss, and symptoms of renal pathologies (hematuria, limb edema, elevated blood pressure).
The treatment strategy depends on the variant of Goodpasture syndrome, the severity of symptoms, and the overall condition of the patient.
In the acute form of the malignant variant, intensive therapy is conducted:
- artificial ventilation of the lungs (AVL);
- oxygen inhalations;
- blood transfusion;
- hemodialysis;
- replenishment of lost fluids and normalization of water-electrolyte balance.
Patients are also prescribed:
- pulse therapy with methylprednisolone — the patient is briefly administered certain types of glucocorticoids in high doses, which helps reduce the production of autoimmune antibodies and the frequency of developing complications;
- combined pulse therapy — administering a combination of corticosteroid hormonal agents and cytostatic drugs also has an immunosuppressive effect; after laboratory and radiological indicators return to normal, the patient is transferred to a maintenance therapy regimen;
- monoclonal antibodies — an innovative method based on the ability of drugs to bind to the protein CD20 expressed on the surface membrane of B-lymphocytes and suppress their activity, thus renewing the population of lymphocytic cells and stopping tissue destruction by autoimmune antibodies;
- plasma exchange — a safe method for cleansing plasma from circulating immune complexes through centrifugation; the blood taken from the patient is placed in a centrifuge, where plasma is separated from the erythrocyte mass, which, along with plasma substitutes, is reintroduced into the patient's bloodstream.
How the Diagnosis of the Disease is Conducted
In Israeli clinics, patient examination, differential diagnosis, and treatment strategy development take about three days.
During the initial consultation, the attending physician conducts a thorough examination of the patient, paying attention to skin pallor, facial swelling, and a number of other external signs characteristic of Goodpasture syndrome. Upon auscultation of the lungs, wheezing is heard, the quantity and severity of which increase in the presence of hemoptysis. During the appointment, the specialist compiles a list of necessary diagnostic procedures.
Performing the examinations listed in the orders:
- complete blood count and biochemical analysis — an increased number of leukocytes, a high ESR, anemia indicate the course of the inflammatory process; the biochemical analysis shows excessive levels of urea and creatinine;
- immunological tests — the most indicative is the detection of antibodies specific to the basal membrane of renal glomeruli (anti-GBM) using enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay (RIA);
- sputum analysis;
- chest X-ray;
- kidney and lung biopsy;
- spirometry (determination of external respiratory volume);
- kidney ultrasound;
- electrocardiography (ECG);
- heart ultrasound (Echocardiography).
The results of the studies are reviewed by a commission consisting of the attending physician and narrow-profile specialists. After studying the obtained data, a diagnosis is made and a treatment strategy is developed.
How Much Does Treatment of the Disease Cost
The cost of therapy is always among the questions of medical tourists. It is noted that treatment in Israeli clinics allows patients to save approximately 30% of the funds required in Western European countries and is about 50% cheaper than undergoing a treatment course in the USA.
Advantages of Treatment in Israel
- Highly qualified specialists with extensive experience in treating rare autoimmune diseases.
- Medical centers equipped with modern equipment.
- Accurate diagnosis using modern methods.
- Inclusion of progressive methods and the latest medications in the comprehensive treatment program.
- Affordable prices.
Timely completion of the treatment course significantly improves prognosis and alleviates painful symptoms. Do not waste time, contact the chosen clinic and start treatment immediately.